- Describe the human genome project.
- Describe the advances made possible by recombinant DNA technology.
The Human Genome
This collective body of genes is called the human genome and the project to map it is called the Human Genome Project. The original impetus for this project in the U. S. arose because of interest in the damage to human DNA by radiation, such as that from nuclear weapons. But, from the beginning, it was recognized that the project had enormous commercial potential, especially in the pharmaceutical industry, and could be very valuable in human health.
The announcement in 2001 that mapping of the human genome was complete promised great progress in biology, especially in medicine. Genes function by directing the synthesis of specific proteins and the action of most pharmaceuticals is to alter the activities of proteins, the drug’s target. In some cases proteins are made more active and in others their activity is diminished. Knowledge of the human genome enables a better understanding of protein activity and should facilitate the development of more specific drugs, something that has developed only slowly. For example, the gene responsible for cystic fibrosis was discovered in 1989 by examination of family histories of the disease and only in 2010 were two drugs designed to combat that disease in clinical trials.
Recombinant DNA Technology
Recombinant DNA technology: the process of taking a gene from one organism and inserting it into the DNA of another. Recombinant DNA technology is the latest biochemical analysis that came about to satisfy the need for specific DNA segments. In this process, surrounding DNA from an existing cell is clipped in the desired amount of segments so that it can be copied millions of times.
Recombinant DNA technology engineers microbial cells for producing foreign proteins, and its success solely depends on the precise reading of equivalent genes made with the help of bacterial cell machinery. This process has been responsible for fueling many advances related to modern molecular biology. The last two decades of cloned-DNA sequence studies have revealed detailed knowledge about gene structure as well as its organization. It has provided hints to regulatory pathways with the aid of which gene expression in myriad cell types is controlled by the cells, especially in those organisms having body plan with basic vertebrae structure.
Recombinant DNA technology, apart from being an important tool of scientific research, has also played a vital role in the diagnosis and treatment of various diseases, especially those belonging to genetic disorders.
Some of the recent advances made possible by recombinant DNA technology are:
1. Isolating proteins in large quantities: many recombinant products are now available, including follicle stimulating hormone (FSH), Follistim AQ vial, growth hormone, insulin and some other proteins.
2. Making possible mutation identification: due to this technology, people can be easily tested for mutated protein presence that can lead to breast cancer, neurofibromatosis, and retinoblastoma.
3. Hereditary diseases carrier diagnosis: tests now available to determine if a person is carrying the gene for cystic fibrosis, the Tay-Sachs diseases, Huntington’s disease or Duchenne muscular dystrophy.
4. Gene transfer from one organism to other: the advanced gene therapy can benefit people with cystic fibrosis, vascular disease, rheumatoid arthritis and specific types of cancers.
- This collective body of genes is called the human genome and the project to map it is called the Human Genome Project. Recombinant DNA (rDNA) is widely used in biotechnology, medicine and research. Proteins and other products that result from the use of rDNA technology are found in essentially every western pharmacy, doctor’s or veterinarian’s office, medical testing laboratory, and biological research laboratory.
- Organisms that have been manipulated using recombinant DNA technology, and products derived from those organisms have found their way into many farms, supermarkets, home medicine cabinets, and even pet shops.
- Biochemical products of recombinant DNA technology in medicine and research include: human recombinant insulin, growth hormone, blood clotting factors, hepatitis B vaccine, and diagnosis of HIV infection.
- Biochemical products of recombinant DNA technology in agriculture include: golden rice, herbicide-resistant crops, and insect-resistant crops.